TP508
Healing & repair In trials Human trials
Also called Chrysalin, Rusalatide acetate
A 23-amino-acid peptide copied from a non-clotting region of human thrombin. It signals blood vessel lining cells and stem cells to start repair, improving blood supply at injury sites. It has been tested for diabetic foot ulcers, fracture healing and radiation injury.
Why people take it
What studies report
- Faster closure of diabetic foot ulcers in phase 2
- Faster fracture healing signals in a distal radius trial
- Protection against radiation injury in animals
In practice Unapproved use
- Rarely available; occasional use for stubborn wounds
Reported real-world use, not evidence and not a recommendation.
Worth knowing: Later trials did not clearly confirm the early results and development stalled.
Status: Reached phase 2/3 trials for wounds and fractures. Not approved.
- Route
- Subcutaneous injection, from reconstituted lyophilised powder
- Sequence
- AGYKPDEGKRGDACEGDSGGPFV
- Formula
- C97H146N28O36S
- Molecular weight
- 2312.4 g/mol
- CAS
- 121341-81-9
- Available as
- 5 mg
Educational information only. Nothing here is medical advice, a dosing protocol, or a recommendation to use any compound. Most entries describe substances not approved for human use. Talk to a licensed clinician before acting on anything you read here. How to read these entries.